Clinical Trials Browser

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT06245746 2025-03-21

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Phase 1 Recruiting

9 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Hemorrhage, Infections, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute

Clinical Trials

Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells

PRAGMATIC

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

UF-BMT-LDND-101

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia